The DOI matches its Crossref record; 219 of the 219 references it cites were found in a registry or an index.
Altered Tumor-Cell Glycosylation Promotes Metastasis
Open accessAbstract
Malignant transformation of cells is associated with aberrant glycosylation presented on the cell-surface. Commonly observed changes in glycan structures during malignancy encompass aberrant expression and glycosylation of mucins; abnormal branching of N-glycans; and increased presence of sialic acid on proteins and glycolipids. Accumulating evidence supports the notion that the presence of certain glycan structures correlates with cancer progression by affecting tumor-cell invasiveness, ability to disseminate through the blood circulation and to metastasize in distant organs. During metastasis tumor-cell-derived glycans enable binding to cells in their microenvironment including endothelium and blood constituents through glycan-binding receptors - lectins. In this review, we will discuss current concepts how tumor-cell-derived glycans contribute to metastasis with the focus on three types of lectins: siglecs, galectins, and selectins. Siglecs are present on virtually all hematopoietic cells and usually negatively regulate immune responses. Galectins are mostly expressed by tumor cells and support tumor-cell survival. Selectins are vascular adhesion receptors that promote tumor-cell dissemination. All lectins facilitate interactions within the tumor microenvironment and thereby promote cancer progression. The identification of mechanisms how tumor glycans contribute to metastasis may help to improve diagnosis, prognosis, and aid to develop clinical strategies to prevent metastasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–219 of 219
Antibody therapy for acute myeloid leukaemia
Gasiorowski, R., Clark, G. J., Bradstock, K. F., & Hart, D. N. J. (2013) · British Journal of Haematology · doi:10.1111/bjh.12691 · Cited by 60
Matsuura, N., Narita, T., Hiraiwa, N., Hiraiwa, M., Murai, H., Iwase, T., Funahashi, H., Tuneo, I. M. A. I., Takagi, H., & Kannagi, R. (1998) · International Journal of Oncology · doi:10.3892/ijo.12.5.1157 · Cited by 56
Stübke, K., Wicklein, D., Herich, L., Schumacher, U., & Nehmann, N. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.02.019 · Cited by 52
Coexpression of MUC1 mucin peptide core and the thomsen-friedenreich antigen in colorectal neoplasms
Baldus, S. E., Hanisch, F., Kotlarek, G. M., Zirbes, T. K., Thiele, J., Isenberg, J., Karsten, U. R., Devine, P. L., & Dienes, H. P. (1998) · Cancer · Cited by 50
Radhakrishnan, P., Chachadi, V. B., Lin, M., Singh, R. K., Kannagi, R., & Cheng, P. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.05.019 · Cited by 49
Marmey, B., Boix, C., Barbaroux, J.-B., Dieu‐Nosjean, M., Diebold, J., Audouin, J., Fridman, W. H., Mueller, C. G., & Molina, T. J. (2005) · Human Pathology · doi:10.1016/j.humpath.2005.09.016 · Cited by 45
Negative regulation of leucocyte functions by CD33-related siglecs
Avril, T., Attrill, H. L., Zhang, J., Raper, A., & Crocker, P. R. (2006) · Biochemical Society Transactions · doi:10.1042/bst0341024 · Cited by 45
Hill, C. A. S., Farooqui, M., Mitcheltree, G., et al. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-79 · Cited by 43
Involvement of p38α Mitogen-activated Protein Kinase in Lung Metastasis of Tumor Cells
Matsuo, Y., Amano, S., Furuya, M., Namiki, K., Sakurai, K., Nishiyama, M., SUDO, T., Tatsumi, K., Kuriyama, T., Kimura, S., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604371200 · Cited by 40
Yin, X., Rana, K., Ponmudi, V., & King, M. R. (2010) · Carbohydrate Research · doi:10.1016/j.carres.2010.07.028 · Cited by 40
T-Antigen in normal and neoplastic urothelium
Limas, C., & Lange, P. H. (1986) · Cancer · doi:10.1002/1097-0142(19860915)58:6<1236::aid-cncr2820580611>3.0.co;2-i · Cited by 39
Matsumoto, Y., Zhang, Q., Akita, K., Nakada, H., Hamamura, K., Tokuda, N., Tsuchida, A., Matsubara, T., Hori, T., Okajima, T., et al. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.01.086 · Cited by 35
Metastatic Growth Progression Caused by PSGL-1–Mediated Recruitment of Monocytes to Metastatic Sites
Hoos, A., Protsyuk, D., & Borsig, L. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0946 · Cited by 35
Self-citationRadhakrishnan, P., Grandgenett, P. M., Mohr, A. M., Bunt, S. K., Yu, F., Chowdhury, S., & Hollingsworth, M. A. (2013) · International Journal of Cancer · doi:10.1002/ijc.28322 · Cited by 34
Berge, Z. L., & Collins, M. P. (1995) · Medical Entomology and Zoology · Cited by 32
Barrow, H., Tam, B., Duckworth, C. A., Rhodes, J. M., & Yu, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059792 · Cited by 30
Correction: Cosmc Mutation in Cancer
(2008) · Cancer Research · doi:10.1158/0008-5472.can-68-8-cor2 · Cited by 29
Expression of the high-affinity selectin glycan ligand C2–O–sLeX by colon carcinoma cells
Hill, C. A. S., Bullard, K. M., & Walcheck, B. K. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.06.038 · Cited by 27
Borsig, L. (2011) · Springer eBooks · doi:10.1007/978-3-642-16833-8_3 · Cited by 11
Self-citation
Cited by
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
“The role of selectin interactions in a variety of normal and pathological conditions like inflammation and cancer is now understood (309, (916) (917) (918) (919) (920) (921) , and therapeutic approaches are in evaluation (921) (922) (923) .”
BackgroundProtein Glycosylation in Cancer
Stowell, S. R., Ju, T., & Cummings, R. D. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040438 · Cited by 873
Nanoparticles Coated with Neutrophil Membranes Can Effectively Treat Cancer Metastasis
Kang, T., Zhu, Q., Wei, D., Feng, J., Yao, J., Jiang, T., Song, Q., Wei, X., Chen, H., Gao, X., et al. (2017) · ACS Nano · doi:10.1021/acsnano.6b06477 · Cited by 551
Hallmarks of glycosylation in cancer
Munkley, J., & Elliott, D. J. (2016) · Oncotarget · doi:10.18632/oncotarget.8155 · Cited by 521
Sialic acids sweeten a tumor's life
Büll, C., Stoel, M. A., den Brok, M. H., & Adema, G. J. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0728 · Cited by 496
Metadata
- Authors
- Häuselmann, I., & Borsig, L.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2014
- Volume
- 4
- Pages
- 28-28
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W2134294354
- Cited by
- 382
- References
- 219
- FWCI
- 14.84
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.